Breaking news

Cypriot Passport Ranks 13th Globally for Travel Freedom

by THEFUTURE.TEAM

August 1, 2024

The Cypriot passport has achieved an impressive 13th position in the global ranking for travel freedom, according to the latest report by Henley & Partners, an esteemed firm specialising in global citizenship and residence advisory. This notable ranking reflects the strength and versatility of the Cypriot passport, granting its holders extensive travel privileges worldwide.

The Henley Passport Index, which assesses the travel access provided by different nations’ passports, has placed Cyprus in this prestigious position based on the number of destinations its citizens can visit without a prior visa. As of the latest update, Cypriot passport holders enjoy visa-free or visa-on-arrival access to 178 countries and territories, underscoring the significant mobility and convenience afforded by Cypriot citizenship.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

This achievement is a testament to Cyprus’s robust diplomatic relationships and its standing within the international community. The country’s EU membership plays a pivotal role in this high ranking, facilitating visa-free travel across the Schengen Area and numerous other countries. Additionally, Cyprus’s bilateral agreements and participation in various international organisations further enhance its passport’s global reach.

The high ranking of the Cypriot passport is particularly advantageous for business professionals, frequent travellers, and those seeking international opportunities. It enables seamless travel for business, tourism, and personal purposes, reducing the administrative burden and costs associated with visa applications. This ease of travel is a significant asset for Cypriots, fostering greater global mobility and connectivity.

Moreover, the strength of the Cypriot passport contributes positively to the country’s attractiveness as a destination for foreign investors and expatriates. The ability to travel freely to a wide array of countries is a compelling factor for individuals considering Cyprus as a base for business or residence. This aspect enhances the island’s reputation as a favourable location for international business operations and high-net-worth individuals seeking global mobility.

The rise of the Cypriot passport in the Henley Passport Index also reflects the ongoing efforts by the Cypriot government to bolster its international ties and enhance the nation’s global standing. Diplomatic initiatives, economic agreements, and collaborative efforts with other countries have played a crucial role in expanding the travel freedoms enjoyed by Cypriot citizens.

In addition to the practical benefits, the ranking is a source of national pride, highlighting Cyprus’s successful navigation of global diplomatic and economic landscapes. It underscores the island’s commitment to maintaining strong international relations and ensuring that its citizens can enjoy the benefits of extensive travel access.

Despite its high ranking, the Cypriot government continues to work towards further enhancing the passport’s strength. Ongoing negotiations and efforts to establish new visa-waiver agreements aim to expand the list of accessible destinations, ensuring that Cypriot passport holders can enjoy even greater travel freedoms in the future.

The Future Forbes Realty Global Properties

Blood Proteins May Signal Prostate Cancer Risk More Than 15 Years Before Diagnosis

by THEFUTURE.TEAM

October 27, 2026

Distinctive proteins in men’s blood may offer clues to prostate cancer risk more than 15 years before a diagnosis, according to research from the University of Oxford. The findings could help scientists better understand why some prostate cancers become aggressive while others grow slowly and never cause serious harm.

Researchers analyzed blood samples from 2,555 men collected between 1992 and 2000. Of those participants, 982 were later diagnosed with prostate cancer; the remaining 1,573 served as a comparison group. The team measured more than 6,000 proteins in the samples, which had been collected years—and, in some cases, more than 15 years—before diagnosis.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Protein Patterns Were Linked To Different Risks

The analysis identified proteins associated with prostate cancer risk overall, as well as proteins linked specifically to more aggressive or fast-growing forms of the disease. Higher levels of certain immune-system proteins, including GZMK and ANXA2, were associated with a lower long-term risk.

“Finding proteins linked to known prostate cancer driver genes in blood collected years before diagnosis gives us new insights into the earliest stages of the disease,” said Karl Smith-Byrne, the study’s corresponding author at Oxford.

The results, published in European Urology, are significant because prostate cancer is not a single, uniform disease. Many tumors grow slowly and may never threaten a patient’s health, while others progress rapidly and can be life-threatening. A clearer way to distinguish between these outcomes could eventually help improve how clinicians assess risk.

Promising Findings, Not A Screening Test

The researchers stressed that the protein patterns are not ready to be used as a screening test. The associations need further validation before they can inform clinical decisions, and the study does not establish that the proteins cause cancer or that measuring them can predict an individual’s outcome.

“Ultimately, we hope this will help us understand the biology of aggressive prostate cancer and identify markers that could improve how we assess risk in the future,” said first author Zhe Huang, a postdoctoral epidemiologist at Oxford Population Health.

Research Could Point To New Prevention Strategies

Prostate cancer is the most commonly diagnosed cancer among men in the European Union and the second most common worldwide, after lung cancer. In the EU, approximately 330,000 cases are diagnosed and 75,000 men die from the disease each year.

By identifying biological signals that appear long before diagnosis, the research may help scientists investigate the pathways involved in aggressive disease. Smith-Byrne said that, alongside existing and future genetic evidence, the findings could help reveal pathways that might ultimately be targeted to prevent aggressive prostate cancer.